Interv Akut Kardiol. 2005;4(3):140-141

Percutaneous coronary intervention in diabetics after coronary artery bypass grafting

Ota Hlinomaz
I. interní kardioangiologická klinika FN u sv. Anny v Brně

Komentář k práci Brtko M, ©»ásek P, Polanský P, Bis J, Černohorský D, Vojáček J, Červinka P. Primární úspěąnost a střednědobý efekt perkutánní koronární intervence u diabetiků s anamnézou chirurgické revaskularizace myokardu; porovnání s nediabetiky. Interv Akut Kardiol 2005; 4: 142–147.

Keywords: -

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hlinomaz O. Percutaneous coronary intervention in diabetics after coronary artery bypass grafting. Interv Akut Kardiol. 2005;4(3):140-141.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mathew V, Gersh BJ, Williams BA, et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial. Circulation 2004; 109: 476-480. Go to original source... Go to PubMed...
    2. Barsness GW, Peterson ED, Ohman EM, et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 1997; 96: 2551-2556. Go to original source... Go to PubMed...
    3. Steg PG, Feldman LJ. Percutaneous coronary intervention in diabetics with prior coronary artery bypass surgery: sweet or sour? Eur Heart J 2002; 23: 1411-1412. Go to original source... Go to PubMed...
    4. Safley DM, Marso SP. Diabetes and percutaneous coronary revascularization in the drug-eluting stent era. Herz 2004; 29: 542-550. Go to original source... Go to PubMed...
    5. The BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000; 35: 1122-1129. Go to original source... Go to PubMed...
    6. Silber S, Albertsson P, Avilés FF, et al. Guidelines for percutaneous coronary interventions. Eur Heart J 2005; 26: 804-847. Go to original source... Go to PubMed...
    7. Marso SP, Bliven BD, House JA, et al. Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality. Eur Heart J 2003; 24: 1323-1328. Go to original source... Go to PubMed...
    8. Mathew V, Wilson SH, Barsness GW, Frye RL, Lennon R, Holmes DR. Comparative outcomes of percutaneous coronary interventions in diabetics vs non-diabetics with prior coronary artery bypass grafting. Eur Heart J 2002; 23: 1456-1464. Go to original source... Go to PubMed...
    9. Brtko M, ©»ástek J, Polanský P, et al. Primární úspěąnost a střednědobý efekt perkutánní koronární intervence u diabetiků s anamnézou chirurgické revaskularizace myokardu; porovnání s nediabetiky. Interv Akut Kardiol 2005; 4: 142-147.
    10. Abizaid A, Costa MA, Blanchard D, et al. on behalf of the RAVEL Investigators. Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL trial. Eur Heart J 2004; 25: 107-112. Go to original source... Go to PubMed...
    11. Moussa I, Leon MB, Baim DS, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients. A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004; 109: 2273-2278. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.